"Cardiovascular Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Descriptor ID |
D002318
|
| MeSH Number(s) |
C14
|
| Concept/Terms |
Cardiovascular Diseases- Cardiovascular Diseases
- Cardiovascular Disease
- Disease, Cardiovascular
- Diseases, Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Cardiovascular Diseases".
Below are MeSH descriptors whose meaning is more specific than "Cardiovascular Diseases".
This graph shows the total number of publications written about "Cardiovascular Diseases" by people in this website by year, and whether "Cardiovascular Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 0 | 3 |
| 1996 | 4 | 1 | 5 |
| 1997 | 7 | 0 | 7 |
| 1998 | 1 | 2 | 3 |
| 1999 | 4 | 4 | 8 |
| 2000 | 6 | 1 | 7 |
| 2001 | 2 | 1 | 3 |
| 2002 | 4 | 2 | 6 |
| 2003 | 6 | 6 | 12 |
| 2004 | 24 | 8 | 32 |
| 2005 | 13 | 8 | 21 |
| 2006 | 26 | 7 | 33 |
| 2007 | 31 | 7 | 38 |
| 2008 | 22 | 6 | 28 |
| 2009 | 29 | 11 | 40 |
| 2010 | 21 | 9 | 30 |
| 2011 | 37 | 15 | 52 |
| 2012 | 35 | 22 | 57 |
| 2013 | 44 | 14 | 58 |
| 2014 | 56 | 17 | 73 |
| 2015 | 55 | 13 | 68 |
| 2016 | 71 | 13 | 84 |
| 2017 | 39 | 13 | 52 |
| 2018 | 71 | 11 | 82 |
| 2019 | 73 | 12 | 85 |
| 2020 | 86 | 11 | 97 |
| 2021 | 87 | 10 | 97 |
| 2022 | 97 | 2 | 99 |
| 2023 | 90 | 3 | 93 |
| 2024 | 76 | 16 | 92 |
| 2025 | 51 | 8 | 59 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiovascular Diseases" by people in Profiles.
-
Trends in blood-based metabolic and cardiovascular risk profiles in men during treatment for testosterone deficiency: a longitudinal, retrospective cohort study. J Sex Med. 2025 Sep 04; 22(9):1564-1571.
-
Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled Analysis. J Am Coll Cardiol. 2025 Oct 07; 86(14):1046-1056.
-
Reproductive milestones, use of menopausal hormone therapy, and risk of hearing loss: A life course study of 214 327 women. Maturitas. 2025 Oct; 201:108685.
-
Association of a Veterans Affairs Toxic Exposure Medical Evaluation with Symptom-related Care. Ann Am Thorac Soc. 2025 Aug; 22(8):1176-1182.
-
Are there rural-urban disparities in cardiovascular disease hospitalization and other outcomes in people with gout? A nationwide U.S. study. Rheumatology (Oxford). 2025 Aug 01; 64(8):4744-4749.
-
Overview of Australia's state-wide cardiovascular program and reflections on its piloting between 2021 and 2024. Health Policy. 2025 Nov; 161:105407.
-
Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations: What Clinicians Need to Know? Curr Atheroscler Rep. 2025 Jul 21; 27(1):73.
-
The overlooked impact of background diet and adherence in nutrition trials. Food Funct. 2025 Jul 14; 16(14):5733-5743.
-
DNA Methylation Signatures of Cardiovascular Health Provide Insights Into Diseases. Circulation. 2025 Aug 19; 152(7):436-449.
-
Advanced ocular drug delivery in microgravity: Nanotherapeutic applications as cardiovascular and ophthalmic countermeasures. Nanomedicine. 2025 Aug; 68:102845.